國立虎尾科技大學 |

Actinobacteria = Microbiology to Synthetic Biology /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Actinobacteria/ edited by Loganathan Karthik.
其他題名:	Microbiology to Synthetic Biology /
其他作者:	Karthik, Loganathan.
面頁冊數:	XV, 276 p. 1 illus.online resource. :
Contained By:	Springer Nature eBook
標題:	Industrial Microbiology. -
電子資源:	https://doi.org/10.1007/978-981-16-5835-8
ISBN:	9789811658358

Actinobacteria = Microbiology to Synthetic Biology /
ActinobacteriaMicrobiology to Synthetic Biology /[electronic resource] :edited by Loganathan Karthik. - 1st ed. 2022. - XV, 276 p. 1 illus.online resource.

Chapter 1. Actinomycetes: Microbiology to Systems Biology -- Chapter 2. Diversity of actinobacteria in various habitats -- Chapter 3. Traditional Screening and Genome Guided Screening of Natural Products from Actinobacteria -- Chapter 4. The relationship between actinobacteria and rice -- Chapter 5.Non-ribosomally and ribosomally synthesized bioactive peptides – NRPS and RiPPs from actinobacteria -- Chapter 6. Genome Data Mining, Chemistry and Bioactivity of Sesquiterpenes from Actinobacteria -- Chapter 7. Genome Data Mining, Chemistry and Bioactivity of Sesquiterpenes from Actinobacteria -- Chapter 8. Cloning and Heterologous expression of Natural products from Actinobacteria -- Chapter 9. Synthetic Biology and Metabolic Engineering in Actinobacteria for Natural Product Production -- Chapter 10. CRISPR ERA: CURRENT APPLICATIONS AND FUTURE PERSPECTIVES ON ACTINOBACTERIA -- Chapter 11. Uncultured Actinobacteria and Reverse engineering and Artificial Intelligence role in future -- Chapter 12. Cultivation and Diversity of Marine Actinomycetes: Molecular Approaches and Bioinformatics Tools -- Chapter 13. Antimicrobial Potential and Metabolite Profiling of Marine Actinobacteria -- Chapter 14. Pharmacology of FDA Approved Medicines from Actinobacteria.

This book summarizes the basics of actinobacteria, from microbiology to synthetic biology. It focuses on diversity, NRPS, sesquiterpenes, lantipeptide, bioinformatics apparatuses, cloning, CRISPR, reverse engineering, FDA supported medications, and marine actinobacteria. It also covers the latest trends in drug discovery from actinobacteria, and introduces several recently developed bioinformatics and synthetic biology tools to explore new antibiotics from actinobacteria. Many natural products such as polyketides, isoprenoids, phenazines, peptides, indolocarbarbazoles, sterols, and others have been isolated and characterized from actinobacteria. Some products are synthesized by the non-ribosomal peptide synthetases (NRPSs), polyketide synthases (PKSs), or other functional genes. Although genome sequencing has uncovered the differing qualities of these chemicals, recognizing new items and their biosynthetic pathways is still under examination. Cryptic metabolic pathways have been explored using molecular techniques or culture-dependent approaches. In recent years, researchers’ primary interest is to identify the specific conditions or agents that wake the cryptic antibiotics. Several bioinformatics and synthetic biology tools were developed to explore new antibiotics from actinobacteria. The book comprises 14 chapters with different aspects of application and utilization of actinomycetes from the microbiology; systems biology, pharmacology of natural products, bioinformatics, actinomycete and its diversity, CRISPR, artificial Intelligence, synthetic biology, metabolic engineering, expressional studies, and biosynthetic gene clusters. The book delivers useful information on actinomyces to researchers, novices in genome designing, specialists, clinicians, policymakers, and professionals.

ISBN: 9789811658358

Standard No.: 10.1007/978-981-16-5835-8doiSubjects--Topical Terms:

559618
Industrial Microbiology.

LC Class. No.: QH324

Dewey Class. No.: 570.724

Actinobacteria = Microbiology to Synthetic Biology /
LDR:04430nam a22003975i 4500 001 1093639
003 DE-He213
005 20220429000518.0
007 cr nn 008mamaa
008 221228s2022 si | s |||| 0|eng d
020 $a 9789811658358 $9 978-981-16-5835-8
024 7 $a 10.1007/978-981-16-5835-8 $2 doi
035 $a 978-981-16-5835-8
050 4 $a QH324
072 7 $a PSB $2 bicssc
072 7 $a SCI010000 $2 bisacsh
072 7 $a PSE $2 thema
082 0 4 $a 570.724 $2 23
245 1 0 $a Actinobacteria $h [electronic resource] : $b Microbiology to Synthetic Biology / $c edited by Loganathan Karthik.
250 $a 1st ed. 2022.
264 1 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2022.
300 $a XV, 276 p. 1 illus. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Chapter 1. Actinomycetes: Microbiology to Systems Biology -- Chapter 2. Diversity of actinobacteria in various habitats -- Chapter 3. Traditional Screening and Genome Guided Screening of Natural Products from Actinobacteria -- Chapter 4. The relationship between actinobacteria and rice -- Chapter 5.Non-ribosomally and ribosomally synthesized bioactive peptides – NRPS and RiPPs from actinobacteria -- Chapter 6. Genome Data Mining, Chemistry and Bioactivity of Sesquiterpenes from Actinobacteria -- Chapter 7. Genome Data Mining, Chemistry and Bioactivity of Sesquiterpenes from Actinobacteria -- Chapter 8. Cloning and Heterologous expression of Natural products from Actinobacteria -- Chapter 9. Synthetic Biology and Metabolic Engineering in Actinobacteria for Natural Product Production -- Chapter 10. CRISPR ERA: CURRENT APPLICATIONS AND FUTURE PERSPECTIVES ON ACTINOBACTERIA -- Chapter 11. Uncultured Actinobacteria and Reverse engineering and Artificial Intelligence role in future -- Chapter 12. Cultivation and Diversity of Marine Actinomycetes: Molecular Approaches and Bioinformatics Tools -- Chapter 13. Antimicrobial Potential and Metabolite Profiling of Marine Actinobacteria -- Chapter 14. Pharmacology of FDA Approved Medicines from Actinobacteria.
520 $a This book summarizes the basics of actinobacteria, from microbiology to synthetic biology. It focuses on diversity, NRPS, sesquiterpenes, lantipeptide, bioinformatics apparatuses, cloning, CRISPR, reverse engineering, FDA supported medications, and marine actinobacteria. It also covers the latest trends in drug discovery from actinobacteria, and introduces several recently developed bioinformatics and synthetic biology tools to explore new antibiotics from actinobacteria. Many natural products such as polyketides, isoprenoids, phenazines, peptides, indolocarbarbazoles, sterols, and others have been isolated and characterized from actinobacteria. Some products are synthesized by the non-ribosomal peptide synthetases (NRPSs), polyketide synthases (PKSs), or other functional genes. Although genome sequencing has uncovered the differing qualities of these chemicals, recognizing new items and their biosynthetic pathways is still under examination. Cryptic metabolic pathways have been explored using molecular techniques or culture-dependent approaches. In recent years, researchers’ primary interest is to identify the specific conditions or agents that wake the cryptic antibiotics. Several bioinformatics and synthetic biology tools were developed to explore new antibiotics from actinobacteria. The book comprises 14 chapters with different aspects of application and utilization of actinomycetes from the microbiology; systems biology, pharmacology of natural products, bioinformatics, actinomycete and its diversity, CRISPR, artificial Intelligence, synthetic biology, metabolic engineering, expressional studies, and biosynthetic gene clusters. The book delivers useful information on actinomyces to researchers, novices in genome designing, specialists, clinicians, policymakers, and professionals.
650 2 4 $a Industrial Microbiology. $3 559618
650 2 4 $a Drug Delivery. $3 1366630
650 0 $a Industrial microbiology. $3 600066
650 0 $a Drug delivery systems. $3 581921
650 0 $a Bioinformatics. $3 583857
650 0 $a Synthetic Biology. $3 1004144
700 1 $a Karthik, Loganathan. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1401609
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789811658341
776 0 8 $i Printed edition: $z 9789811658365
776 0 8 $i Printed edition: $z 9789811658372
856 4 0 $u https://doi.org/10.1007/978-981-16-5835-8
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)